| 教員紹介トップページへ | 三重大学トップページへ |
| 職名 | 教授 | |||||||||
| 氏名 | 俵 功 |
|||||||||
| 生年月 | ||||||||||
|
||||||||||
| TEL | ||||||||||
| FAX | ||||||||||
| 個人のホームページ | ||||||||||
| 学歴 | ||||||||||
| 学位 | 2003.03 博士（医学） 岡山大学
1994.03 医学士 三重大学 |
|||||||||
| 所属学会 | ||||||||||
| 社会活動 | ||||||||||
| 職歴 | ||||||||||
| 学術（芸術）賞 | ||||||||||
| 専門分野 | ||||||||||
| 現在の研究課題 | ||||||||||
| 担当科目 | ||||||||||
| 主な業績等 | Voriconazole as a secondary prophylaxis for cryptococcal meningitis during hematopoietic stem cell transplantation. 共著 2021 IDCases 25 e01241-
Acquisition of JAK2 V617F to CALR-mutated clones accelerates disease progression and might enhance growth capacity. 共著 2021.09 British journal of haematology 194 e89-e92 Donor-derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation. 共著 2021.08 Immunity, inflammation and disease Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantation. 共著 2021.07 International journal of hematology MPL exon 10 mutations other than canonical MPL W515L/K mutations identified by in-house MPL exon 10 direct sequencing in essential thrombocythemia. 共著 2021.05 International journal of hematology 113 618-621 [Successful treatment with cyclosporine in a patient with rituximab-refractory thrombocytopenic purpura]. 共著 2021.03 [Rinsho ketsueki] The Japanese journal of clinical hematology 62 176-179 Tenascin-C in cardiac disease: a sophisticated controller of inflammation, repair, and fibrosis. 共著 2020.11 American journal of physiology. Cell physiology 319 C781-C796 CD4(+) T cells support polyfunctionality of cytotoxic CD8(+) T cells with memory potential in immunological control of tumor. 共著 2020.06 Cancer science 111 1958-1968 Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy. 共著 2020.05 International journal of hematology 111 686-691 [Therapy-related acute promyelocytic leukemia with complex karyotype accompanied by cryptic PML/RARA on chromosome 15 by metaphase FISH]. 共著 2020.11 [Rinsho ketsueki] The Japanese journal of clinical hematology 61 1577-1583 [Successful treatment with a combination of elotuzumab, lenalidomide and dexamethasone of extramedullary disease in a patient with refractory multiple myeloma]. 共著 2019.03 [Rinsho ketsueki] The Japanese journal of clinical hematology 61 223-227 Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers. 共著 2018.03 Oncotarget 9 14909-14921 [Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab]. 共著 2018.02 臨床血液 The Japanese journal of clinical hematology 59 178-181 Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS. 共著 2017.11 Blood 130 1985-1994 CXCL12-CXCR4 Axis Is Required for Contact-Mediated Human B Lymphoid and Plasmacytoid Dendritic Cell Differentiation but Not T Lymphoid Generation. 共著 2017.10 Journal of immunology (Baltimore, Md. : 1950) 199 2343-2355 Signal-transducing adaptor protein-2 promotes generation of functional long-term memory CD8+ T cells by preventing terminal effector differentiation. 2017.05 Oncotarget 8 30766-30780 MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma. 共著 2017.04 Cancer 123 1166-1173 |
|||||||||